Thalassaemia gene therapy trial shows 'encouraging' results Scientists say they are "excited" by the results of a gene therapy trial for the inherited blood disorder beta-thalassaemia, which reduced the need for blood transfusions
Double-blind, placebo-controlled studies have shown that both women with desire/interest/arousal/orgasm disorders and those with normal sexual functioning experienced improved desire, arousal, and orgasm with its use
Detoxifies and boosts skin health
The overall tumour incidences were 100%, 96%, and 98% in males and 37%, 31%, and 33% in females, respectively, in control, low-dose, and high-dose groups
Our product range includes Resveratrol, Glutathione, NAD+, NMN, Curcumin, Methyl B12 & Vitamin D, focused on improving healthspan and longevity